- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Swissray introduces ddR Combi Trauma
Digital radiography pioneer Swissray is introducing the ddRCombi Trauma at the RSNA meeting. The system enables trauma and other emergency patients to be imaged from head to toe -- both AP and laterally -- easily and without being moved.
Digital radiography pioneer Swissray is introducing the ddRCombi Trauma at the RSNA meeting. The system enables trauma and other emergency patients to be imaged from head to toe - both AP and laterally - easily and without being moved.
The ddRCombi features a fixed table with elevating base, four-way floating top, and automatic detector positioning for cross-table imaging. The table can be controlled with a single button push on a wireless handheld remote control. Fully processed images are available in about five seconds.
"We're trying to build a broad line of products focused on key segments of the market," said Rex Harmon, vice president of marketing and public relations manager for Swissray. "The ddRCombi Trauma is important. The busiest component of a hospital that requires a high-volume, high-throughput radiography capability is an emergency room."
Swissray is also displaying several works-in-progress on the ddRCombi:
- dual-energy imaging, for separation of bone and soft-tissue image elements
- computer-aided diagnosis
- Osteocad, providing bone mineral analysis and measurements derived from a Swissray ddR-acquired digital hand radiograph
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
